Pages that link to "Q39963168"
Jump to navigation
Jump to search
The following pages link to Pregabalin and gabapentin inhibit substance P-induced NF-kappaB activation in neuroblastoma and glioma cells. (Q39963168):
Displaying 11 items.
- Analgesic effect of intrathecal gabapentin in a rat model of persistent muscle pain. (Q34458185) (← links)
- Alpha 2 Delta (α2δ) Ligands, Gabapentin and Pregabalin: What is the Evidence for Potential Use of These Ligands in Irritable Bowel Syndrome (Q35042476) (← links)
- The Effects of Intrathecal and Systemic Gabapentin on Spinal Substance P Release (Q35945726) (← links)
- Pain management in patients with inflammatory bowel disease: insights for the clinician (Q36220453) (← links)
- In search of druggable targets for GBM amino acid metabolism (Q36293108) (← links)
- Pregabalin in neuropathic pain: evidences and possible mechanisms (Q37559818) (← links)
- Possible Sites of Therapeutic Action in Restless Legs Syndrome: Focus on Dopamine and α<sub>2</sub>δ Ligands (Q37895053) (← links)
- Implications and mechanism of action of gabapentin in neuropathic pain. (Q38084171) (← links)
- Neuroprotective effects of neurokinin receptor one in dopaminergic neurons are mediated through Akt/PKB cell signaling pathway (Q39476426) (← links)
- Blocking αδ-1 Subunit Reduces Bladder Hypersensitivity and Inflammation in a Cystitis Mouse Model by Decreasing NF-kB Pathway Activation (Q64100782) (← links)
- Extracellular Matrix Remodeling and Modulation of Inflammation and Oxidative Stress by Sulforaphane in Experimental Diabetic Peripheral Neuropathy (Q88499143) (← links)